Midatech Pharma Plc Ret. on equity
What is the Ret. on equity of Midatech Pharma Plc?
The Ret. on equity of Midatech Pharma Plc is -192.91%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on LSE compared to Midatech Pharma Plc
What does Midatech Pharma Plc do?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Companies with ret. on equity similar to Midatech Pharma Plc
- General Moly has Ret. on equity of -193.78%
- General Moly has Ret. on equity of -193.78%
- General Moly has Ret. on equity of -193.78%
- Totally Hip Technologies has Ret. on equity of -193.63%
- Sarytogan Graphite has Ret. on equity of -193.61%
- Jack Nathan Medical Corp has Ret. on equity of -193.17%
- Midatech Pharma Plc has Ret. on equity of -192.91%
- Applied Genetic Technologies Corp has Ret. on equity of -192.90%
- Krakatoa Resources has Ret. on equity of -192.87%
- Canopy Growth has Ret. on equity of -192.43%
- Hycroft Mining has Ret. on equity of -192.29%
- Revolve Renewable Power Corp has Ret. on equity of -192.27%
- GeNeuro SA has Ret. on equity of -192.10%